Ligand validation:3V13

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3V13_IMD_A_485	68%	71%	0.102	0.914	0.52	0.61	-	-	0	0	100%	1
4AOR_IMD_C_1248	98%	69%	0.059	0.98	0.31	0.88	-	-	1	0	100%	1
4NCY_IMD_A_314	79%	50%	0.109	0.953	0.7	1.2	-	-	2	0	100%	1
1Y5A_IMD_T_3	52%	71%	0.128	0.883	0.43	0.69	-	-	0	0	100%	1
1Y59_IMD_T_9	48%	76%	0.171	0.916	0.39	0.54	-	-	0	0	100%	1
1Y5U_IMD_T_12	43%	72%	0.159	0.883	0.38	0.69	-	-	1	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.